Biomarkers of Perioperative Oxidative Stress

Abstract

Perioperative oxidative stress is a significant contributor to post-surgical complications, particularly in vulnerable populations such as the elderly or those with preexisting comorbidities. The identification and quantification of biomarkers related to oxidative stress during the perioperative period provide critical insights into patient risk stratification, prognosis, and potential therapeutic interventions. Recent advancements in analytical techniques have enabled clinicians to monitor oxidative stress through a variety of biomarkers, including malondialdehyde, F2-isoprostanes, and protein carbonyls, among others. This review synthesizes current evidence regarding the epidemiology, mechanisms, risk factors, clinical manifestations, diagnostic approaches, and management strategies for perioperative oxidative stress, with an emphasis on the practical application of biomarkers in improving patient outcomes.

Introduction

Oxidative stress, defined as an imbalance between the production of reactive oxygen species (ROS) and antioxidant defenses, is a ubiquitous phenomenon during the perioperative period. Surgical trauma, anesthetic agents, and patient-specific factors collectively trigger excessive ROS generation, leading to cellular and tissue injury. Timely detection of perioperative oxidative stress via reliable biomarkers is essential for targeted interventions and optimizing perioperative care. This article reviews the latest evidence on perioperative oxidative stress biomarkers, their clinical utility, and implications for patient management in surgical settings.

Epidemiology / Disease Burden

Perioperative oxidative stress is a prevalent phenomenon across all surgical specialties. Studies indicate that up to 70% of patients undergoing major surgery exhibit biochemical evidence of increased oxidative stress. The burden is particularly pronounced in cardiac, vascular, and oncologic surgeries, where oxidative injury is linked to higher rates of postoperative organ dysfunction. Epidemiological data further highlight increased susceptibility in elderly patients and those with chronic diseases such as diabetes, chronic kidney disease, and chronic obstructive pulmonary disease, reflecting a substantial clinical and economic burden.

Pathophysiology

The pathogenesis of perioperative oxidative stress is multifactorial. Surgical trauma induces local and systemic inflammatory responses, leading to activation of phagocytic cells and the mitochondrial respiratory chain, both major sources of ROS. Anesthetic agents and ischemia-reperfusion events further amplify ROS generation. These reactive species damage cellular lipids, proteins, and nucleic acids, culminating in membrane dysfunction, enzyme inactivation, and apoptosis. The body’s endogenous antioxidant systems—such as superoxide dismutase, catalase, and glutathione—are often overwhelmed during major surgery, resulting in a net oxidative burden.

Risk Factors

Numerous factors predispose patients to heightened perioperative oxidative stress. These include advanced age, poor nutritional status, diabetes mellitus, obesity, chronic inflammation, smoking, excessive alcohol intake, and underlying cardiovascular or renal disease. The type and duration of surgery, intraoperative blood loss, use of cardiopulmonary bypass, and inadequate tissue perfusion are additional procedural risk factors. Preoperative assessment of these variables is crucial for identifying high-risk patients and tailoring perioperative management.

Clinical Features

While perioperative oxidative stress itself is a biochemical phenomenon, its clinical manifestations are often indirect. Patients may present with systemic inflammatory response syndrome (SIRS), acute organ dysfunction (such as myocardial injury, acute kidney injury, or postoperative cognitive dysfunction), delayed wound healing, and increased susceptibility to infections. The severity and spectrum of clinical features depend on the extent of oxidative injury, preexisting comorbidities, and the adequacy of perioperative support measures.

Diagnosis

The diagnosis of perioperative oxidative stress relies on the quantification of specific biomarkers. Malondialdehyde (MDA) and F2-isoprostanes are widely recognized markers of lipid peroxidation. Protein carbonyls and advanced oxidation protein products (AOPPs) reflect protein oxidation, while 8-hydroxy-2’-deoxyguanosine (8-OHdG) indicates DNA oxidative damage. Antioxidant capacity can be assessed through measurements of glutathione, superoxide dismutase, and total antioxidant status. Emerging omics-based technologies, including metabolomics and proteomics, are providing novel panels of oxidative stress biomarkers with enhanced sensitivity and specificity. Serial perioperative measurements can help identify patients at risk for adverse outcomes and guide therapeutic interventions.

Treatment & Management

Management strategies for perioperative oxidative stress focus on both prevention and mitigation. Optimization of preoperative health, including nutritional support and cessation of smoking or alcohol, reduces baseline oxidative burden. Intraoperative measures such as maintaining adequate tissue oxygenation, temperature control, and minimizing ischemia-reperfusion injury are critical. Pharmacologic interventions, including antioxidants (e.g., vitamin C, N-acetylcysteine, selenium), have been investigated with variable results. Individualized antioxidant therapy, guided by biomarker levels, may represent a promising approach but requires further validation in large clinical trials.

Recent Advances / Emerging Therapies

Recent advances in the field have focused on high-throughput biomarker discovery and targeted antioxidant therapies. Multi-omics profiling enables comprehensive assessment of oxidative pathways and identification of novel biomarkers with prognostic value. Mitochondria-targeted antioxidants, such as MitoQ and SS-31, are under investigation for their ability to attenuate perioperative oxidative damage. Additionally, point-of-care testing for oxidative stress biomarkers is being developed to facilitate real-time risk assessment and therapeutic monitoring in the perioperative setting. The integration of biomarker-guided interventions into perioperative care pathways holds promise for improving patient outcomes.

Guideline Recommendations

Current guidelines from major anesthesiology and surgical societies emphasize the importance of perioperative risk assessment and optimization of modifiable risk factors. While routine measurement of oxidative stress biomarkers is not yet universally recommended, their use is encouraged in high-risk populations and research settings. Guidelines advocate for evidence-based use of antioxidant therapies, reserving pharmacologic interventions for select patient groups with demonstrated benefit in clinical trials. Ongoing research is expected to inform future guideline updates regarding biomarker integration into standard perioperative protocols.

Conclusion

Biomarkers of perioperative oxidative stress are emerging as valuable tools for improving patient risk stratification, guiding therapeutic interventions, and enhancing postoperative outcomes. Advances in analytical techniques and a deeper understanding of oxidative mechanisms have paved the way for biomarker-driven perioperative care. Further large-scale studies are warranted to validate the clinical utility of existing and novel biomarkers, refine management strategies, and establish standardized protocols for perioperative oxidative stress assessment. Ultimately, integrating biomarker-based approaches into routine practice may contribute to safer surgeries and better recovery trajectories for diverse patient populations.